Ctic stock earnings
WebCTIC Stock Price - CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. ... The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the ... WebStock Price Forecast. The 9 analysts offering 12-month price forecasts for CTI Biopharma Corp have a median target of 10.00, with a high estimate of 15.00 and a low estimate of …
Ctic stock earnings
Did you know?
WebApr 10, 2024 · CTIC Stock Overview. CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. ... Earnings-US$92.99m: Last Reported Earnings. Dec 31, 2024. Next Earnings Date. n/a. Earnings per share (EPS)-0.71: … WebStock Quote. Change Volume 52 Week High 52 Week Low Apr 13, 2024 1:41 PM EDT. Data Provided by Refinitiv. ... Wash. , April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today …
WebCTI BioPharma (CTIC) Stock Price & Analysis. Follow. 855 Followers. Portfolio. CTIC Stock Chart & Stats. Advanced Chart > 1d 5d 3m 6m YTD 1y 3y 5y. Day’s Range $0 - $0. ... WebAug 1, 2024 · Get the latest CTI BioPharma Corp. (CTIC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. ... Financials …
WebApr 9, 2024 · 6 brokers have issued 12 month price targets for CTI BioPharma's shares. Their CTIC share price forecasts range from $9.00 … Web20 hours ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ...
WebApr 10, 2024 · CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? 1 month ago - Zacks Investment Research
WebApr 12, 2024 · While ratings are subjective and will change, the latest CTI BioPharma ( CTIC) rating was a reiterated with a price target of $0.00 to $9.00. The current price CTI … orange ma online assessors databaseWebApr 12, 2024 · While ratings are subjective and will change, the latest CTI BioPharma ( CTIC) rating was a reiterated with a price target of $0.00 to $9.00. The current price CTI BioPharma ( CTIC) is trading at ... orange lynx catWebApr 13, 2024 · As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.1, which is expected to increase to -$0.08 for fiscal year -$0.43 and then to about -$0.29 by fiscal year 2024. orange lyon bellecourWebMar 6, 2024 · CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? orange m\\u0026m characterWebApr 8, 2024 · CTI BioPharma last announced its earnings data on March 6th, 2024. The biopharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, … iphone test wifi signal strengthWeb1 day ago · CTI BioPharma (CTIC) delivered earnings and revenue surprises of -5.71% and 6.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to … orange ma district court docketWebThe Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingSep 2024 , … orange ma livebox windows 10